Prevention of Gastric Insufflation During Positive Pressure Ventilation ?
Is Ultrasound-guided Left Paratracheal Esophagus Pressure More Effective Than Cricoid Pressure to Prevent Gastric Insufflation During Positive Pressure Ventilation ?
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
After Ethics Committee approval of the University of Liège and written informed consent, 90 ASA 1-2 patients aged 18-65 years and scheduled for elective surgery under general anesthesia will be enrolled in the study. Exclusion criteria are body mass index (BMI) above 35; meeting criteria for difficult ventilation and/or intubation, such as oropharyngeal pathology or facial or cervical abnormalities; and risk for aspiration or previous gastric surgery. Patients will be randomly allocated 1:1:1 (30 patients/group) by the method of sealed envelopes to left low paratracheal esophageal compression (LPEC), cricoid pressure (CP), or no pressure intervention (Control). Neck circumference will be measured. No premedication will be given prior to the study interventions.
Part 1: Ultrasound assessment of the esophagus at the left lower paratracheal level
Esophageal examinations will be conducted by ultrasound with the patient supine and head in neutral position. Feasibility of imaging and compressing the esophagus approximately 2-3 cm above the clavicle was assessed as follows:
A linear ultrasound probe (Applio XG iStyle Toshiba with a 14-7 Mhz) was positioned in a transverse (axial) orientation over the left paratracheal area (Figure 1(A)), 2-3 cm above the clavicle. The position of the esophagus in relation to the trachea (left, right or not seen) will be recorded. Once the esophagus will be identified, the antero-posterior diameter (mm) will be measured and compared before and after applying an estimated pressure of 30 N (as described below) or until a bony contact will be established with the transducer. Esophageal compression will be re-assessed using a paramedian sagittal plane between the trachea and the sternocleidomastoid muscle with the esophagus in sagittal plane. The antero-posterior diameter (mm) measurements will be repeated before and after applying pressure with the transducer. Three consecutive measures for each probe position were recorded.
Part 2: Assessment of the presence of gastric (antral) air With the patients in supine position, a curvilinear transducer (Applio XG iStyle Toshiba with an 8-5 MHz) will be placed on the epigastrium in a paramedian sagittal orientation to identify the antrum. 9 The cross-sectional area of the antrum was measured at the level where both the aorta and upper mesenteric artery were visible. Three consecutive measures were taken (a) before the induction of anesthesia and (b) after 3 min of PPV via face mask. The presence of gastric air insufflation is defined as an increase in cross-sectional area and/or presence of artifacts in the antrum (comet tail, posterior acoustic shadow). 9 These assessments will be performed by a sonographer, blinded to group allocation by a surgical drape placed between the thorax and the abdomen.
Pressure maneuvers Two anesthesiology residents, not informed of the study outcome measurements, will be trained to apply sustained pressure of 30 ± 5 N using an electronic dynamometer (MicroFET2; Hoogan Industries, West Jordan, Utah), until 10 consecutive maneuvers will be measured successfully (30 ± 5 N). For cricoid pressure, the cartilage will be compressed with the thumb and index fingers toward the vertebral bodies (Sellick). For LPEC, the thumb will be placed over the base of the neck on the left side of the trachea 2-3 cm above the clavicle and medial to the sternocleidomastoid muscle (Figure 1(B)).
ASA monitoring will be applied, and anesthesia will be induced with propofol 2.5 mg/kg administered over 45 sec. Remifentanil will be administered with an infusion pump (2 to 3 μg/kg over 60 sec during induction, followed by continuous infusion of 0.05μg /kg/min). After general anesthesia will be induced, PPV was accomplished with a face-mask in pressure-control mode while maintaining a positive inspiratory pressure of 25 cm H2O, (Zeus ventilator, Dräger, Lübeck, Germany). The ventilator settings will be 100% oxygen, I:E ratio 1:2, 15 breaths/min, no positive end-expiratory pressure. Adequacy of ventilation will be documented by chest raise and capnography. Antral measurements will be taken after 3 min of face-mask ventilation by a sonographer blinded to group assignment. Thereafter, the management of anesthesia care will be continued as per institutional standards.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jean François Brichant, MD, PhD
- Phone Number: 0032 43667655
- Email: jfbrichant@chu.ulg.ac.be
Study Contact Backup
- Name: Philippe Gautier, MD
- Phone Number: 0032 477 360031
- Email: p.gautier@skynet.be
Study Locations
-
-
Liege
-
Liège, Liege, Belgium, 4000
- Recruiting
- CHU de Liege
-
Contact:
- Jean Francois Brichant, MD, PhD
- Phone Number: 0032 43667180
- Email: jfbrichant@ulg.chu.ac.be
-
Contact:
- Philippe Gautier, MD
- Phone Number: 0032477360031
- Email: p.gautier@skynet.be
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- elective surgery under general anesthesia
Exclusion Criteria:
- body mass index above 35 meeting criteria for difficult ventilation and /or intubation risk for aspiration or gastric surgery
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
control,
control normal ventilation
|
|
sellick,
ventilation while sellick manoeuvre is applied
|
|
low paratracheal esophagus compression
ventilation while low paratracheal esophagus compression is applied
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
gastric volume
Time Frame: within 10 min of induction of anesthesia
|
With the patients in supine position, a curvilinear transducer (Applio XG iStyle Toshiba with an 8-5 MHz) will be placed on the epigastrium in a paramedian sagittal orientation to identify the antrum.
The cross-sectional area of the antrum will be measured at the level where both the aorta and upper mesenteric artery will be visible
|
within 10 min of induction of anesthesia
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
diameter of the esophagus
Time Frame: within 10 min of induction of anesthesia
|
A linear ultrasound probe (Applio XG iStyle Toshiba with a 14-7 Mhz) will be positioned in a transverse (axial) orientation over the left paratracheal area (Figure 1(A)), 2-3 cm above the clavicle.
The position of the esophagus in relation to the trachea (left, right or not seen) will be recorded.
When the esophagus will be identified, the antero-posterior diameter (mm) will be measured and compared before and after applying an estimated pressure of 30 N.
|
within 10 min of induction of anesthesia
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- ULGANESGAU001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complication of Ventilation Therapy
-
NCT02740075CompletedComplication of Ventilation Therapy
-
NCT02671721CompletedPostoperative Respiratory Complications | Complication of Ventilation Therapy
-
NCT02729610UnknownIntubation Complication | Complication of Ventilation Therapy | Postoperative; Dysfunction Following Cardiac Surgery
-
NCT03420937CompletedObservation of Neuromuscular Block | Complication of Ventilation Therapy | Postoperative Recovery
-
NCT04744909CompletedVentilation Therapy; Complications | Tracheostomy Complication
-
NCT02318810CompletedObservation of Neuromuscular Block | Complication of Ventilation Therapy
-
NCT01992224UnknownAcute Pancreatitis | Complication of Ventilation Therapy
-
NCT03726086CompletedCritical Illness | Mechanical Ventilation Complication | Intubation, Intratracheal | Complication of Ventilation Therapy
-
NCT02442102TerminatedDeglutition Disorders | Mechanical Ventilation Complication | Complication of Ventilation Therapy
-
NCT04763590CompletedAnxiety | Mechanical Ventilation Complication | Cognitive Behavioral Therapy